Floatz logo

Calcium folinate pentahydrate

Drug/Agent Toxicity by Tissue/Organ

Dana-Farber Cancer InstituteSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Drug/Agent Toxicity by Tissue/Organ cohort.

Asset / SponsorPhaseRating
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
Dana-Farber Cancer Institute
Phase 3BB
FLUTICASONE
Scripps Health
Phase 2BB
Busulphan
University of Arizona
Phase 2B
(+)-VINCRISTINE
National Cancer Institute (NCI)
Phase 2B

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →